FDA Food and Drug Administration - Search News

Axsome Therapeutics, FDA and migraine

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

Business Insider · 1h

Axsome Therapeutics announces FDA approval of Symbravo

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in

Seeking Alpha on MSN · 1h

Axsome gets FDA approval for Symbravo for migraine

Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo, a combination of meloxicam and rizatriptan,

FDA, recall

This chocolate recall has been upgraded to FDA’s highest risk level

STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug Administration (FDA), which says consuming the product could “cause serious adverse health consequences or death.”

New York Daily News · 50m

Lay’s recall increased to highest level, could cause ‘death’: FDA

The oversight could result in “death,” at least for those with a milk allergy or sensitivity, says the FDA. FDA initiated the recall on Dec. 13 and announced three days later that it was recalling the chips due to a potential or undeclared allergen. At present, no allergic reactions have been reported.

Newsweek on MSN · 7h

Salad Recall Update as FDA Sets Highest Risk Level

The U.S. Food and Drug Administration ( FDA) has set its highest risk level—a Class I recall—over potential salmonella contamination in salad products.

FDA, Ozempic and chronic kidney disease

FDA clears use of Ozempic to protect kidney health

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, which hasn’t yet proven it can improve outcomes in kidney disease.

The Baltimore Sun · 6h

FDA approves Ozempic to help reduce risk of worsening chronic kidney disease

The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of

HealthDay on MSN · 22h

FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for kidney failure. The U.S. Food and Drug Administration (FDA) has officially approved Ozempic to help reduce the risk of serious kidney complications in people with type 2 diabetes

2hon MSN

US FDA identifies cybersecurity risks in certain patient monitors

The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...

The American Spectator18h

Trump: Look at the Slow-Moving FDA

The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...

4don MSN

Food and Drug Administration wants to put nutrition labels front and center on food products

The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...

6don MSN

Trump administration withdraws FDA plan to ban menthol cigarettes in U.S.

The Trump administrations removed FDA's plan to ban menthol cigarettes. The Biden administration did not finalize the rule ...

Hosted on MSN2d

New Maintenance Dosing Option for Alzheimer's Drug Leqembi Offers Flexibility

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for ...

2d

FDA raises alert on listeria-tainted broccoli sold at Walmart over risk of ‘death’

The recall affects 12-ounce bags of the product, which were sold in 20 states and pose serious health risks if consumed.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results